EIF4G2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.180000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.744600E-01
Normal-vs-Stage2
5.403200E-01
Normal-vs-Stage3
6.759700E-02
Normal-vs-Stage4
8.496000E-01
Stage1-vs-Stage2
7.521800E-01
Stage1-vs-Stage3
1.083630E-01
Stage1-vs-Stage4
8.509600E-01
Stage2-vs-Stage3
1.373780E-01
Stage2-vs-Stage4
6.405200E-01
Stage3-vs-Stage4
1.356820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.066200E-01
Normal-vs-AfricanAmerican
7.991800E-01
Normal-vs-Asian
2.187400E-01
Caucasian-vs-AfricanAmerican
6.935200E-01
Caucasian-vs-Asian
2.384800E-01
AfricanAmerican-vs-Asian
3.532000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.203800E-01
Normal-vs-Female
3.766800E-01
Male-vs-Female
4.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.763800E-01
Normal-vs-Age(41-60Yrs)
9.403400E-01
Normal-vs-Age(61-80Yrs)
3.503400E-01
Normal-vs-Age(81-100Yrs)
4.000800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.501200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.082000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.750400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.395900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.219800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.291000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.686770E-01
Normal-vs-Daily Drinker
1.267040E-01
Normal-vs-Weekly Drinker
2.028400E-01
Normal-vs-Occasional Drinker
8.539200E-01
Normal-vs-Social Drinker
8.574000E-01
Non Drinker-vs-Daily Drinker
6.055600E-01
Non Drinker-vs-Weekly Drinker
9.080800E-01
Non Drinker-vs-Occasional Drinker
2.987900E-02
Non Drinker-vs-Social Drinker
4.475800E-02
Daily Drinker-vs-Weekly Drinker
7.612800E-01
Daily Drinker-vs-Occasional Drinker
1.697840E-02
Daily Drinker-vs-Social Drinker
2.741900E-02
Weekly Drinker-vs-Occasional Drinker
5.152300E-02
Weekly Drinker-vs-Social Drinker
9.231600E-02
Occasional Drinker-vs-Social Drinker
5.442000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.061600E-02
Normal-vs-Grade 2
2.636200E-02
Normal-vs-Grade 3
2.870400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.916400E-01
Grade 1-vs-Grade 3
1.790550E-01
Grade 1-vs-Grade 4
9.061600E-02
Grade 2-vs-Grade 3
2.721000E-01
Grade 2-vs-Grade 4
2.636200E-02
Grade 3-vs-Grade 4
2.870400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.660400E-01
Normal-vs-NonDiabetic
3.881800E-01
Diabetic-vs-NonDiabetic
7.528000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.556400E-01
Normal-vs-NoPancreatitis
4.183200E-01
Pancreatitis-vs-NoPancreatitis
8.188000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.035400E-01
Normal-vs-N1
5.511800E-01
N0-vs-N1
8.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.059000E-01
Normal-vs-TP53-NonMutant
4.813600E-01
TP53-Mutant-vs-TP53-NonMutant
2.168400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
